Stryker Corporation (SYK)
NYSE: SYK · Real-Time Price · USD
377.79
-14.94 (-3.80%)
At close: Aug 1, 2025, 4:00 PM
377.01
-0.78 (-0.21%)
After-hours: Aug 1, 2025, 7:54 PM EDT
Stryker Revenue
Stryker had revenue of $6.02B in the quarter ending June 30, 2025, with 11.07% growth. This brings the company's revenue in the last twelve months to $23.82B, up 11.36% year-over-year. In the year 2024, Stryker had annual revenue of $22.60B with 10.23% growth.
Revenue (ttm)
$23.82B
Revenue Growth
+11.36%
P/S Ratio
6.05
Revenue / Employee
$449,396
Employees
53,000
Market Cap
144.38B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 22.60B | 2.10B | 10.23% |
Dec 31, 2023 | 20.50B | 2.05B | 11.11% |
Dec 31, 2022 | 18.45B | 1.34B | 7.84% |
Dec 31, 2021 | 17.11B | 2.76B | 19.21% |
Dec 31, 2020 | 14.35B | -533.00M | -3.58% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
SYK News
- 1 day ago - Stryker Corporation (SYK) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Stryker raises annual profit forecast on steady demand for surgical devices - Reuters
- 1 day ago - Stryker reports second quarter 2025 operating results - GlobeNewsWire
- 1 day ago - 10 stocks favored to gain up to 30% in a sector that has missed this year's rally - Market Watch
- 3 days ago - Inari Medical, now part of Stryker, launches the all-new InThrill® Thrombectomy System, designed to address arteriovenous access and small vessel thrombus cases - PRNewsWire
- 21 days ago - North America Cystoscopes Market Outlook Report 2025-2033 Featuring Key Companies - Olympus, KARL STORZ, Stryker, PENTAX Medical, Richard Wolf, Ambu, Laborie Medical Technologies - GlobeNewsWire
- 4 weeks ago - Stryker to announce financial results for its second quarter of fiscal year 2025 - GlobeNewsWire
- 5 weeks ago - Stryker receives FDA clearance for Incompass Total Ankle System - Business Wire